3,084
Participants
Start Date
April 28, 2022
Primary Completion Date
December 28, 2023
Study Completion Date
September 30, 2024
HIL-214
2 injections - given on Day 1 and the second given between Day 29 - Day 57
Placebo
2 injections - given on Day 1 and the second given between Day 29 - Day 57
Hospital General Regional Marcelino Velez Santana, Santo Domingo
Instituto de Investigacion Nutricional, Lima
DM Clinical Research, Houston
Cntro de Estudios en Infectologia Pediatrica (CEIP), Santiago de Cali
Policlinico Social del Norte, Bogotá
Hospital Pediátrico Dr. Hugo Mendoza, Santo Domingo
CAIMED - Dominican Center for Clinical Studies, Santo Domingo
Clínica Cruz Jiminian, Santo Domingo
Fundacion Dominicana de Perinatologia Pro Bebe, Santo Domingo
Demedica, San Pedro Sula
INVERIME - Inversiones en Investigación Medica, Tegucigalpa
Investigación Sin Limite, Tegucigalpa
CEVAXIN La Chorrera, La Chorrera
CEVAXIN Av. México, Panama City
Clinical Research Puerto Rico, Guayama
CEVAXIN David, David
CEVAXIN 24 Decembre, Panama City
Lead Sponsor
HilleVax
INDUSTRY